Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach
Author(s):
Sluiter, R.L.; Kievit, W.; Wilt, G.J. van der; Schene, A.H.; Teichert, M.; Coenen, M.J.H.; Schellekens, A.
Published
2018
Publication type
Article / Letter to editor
Cost-effectivenessPharmacogeneticsAlcohol use disorderNaltrexoneAcamprosate
Date issued
2018-12-31
Language
English
Is part of
European Addiction Research (2018), Vol. 24, no. 5, p. 245-254
